Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 2—February 2026

Dispatch

Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025

Natalie N. Tarbuck, John Franks, Jeremy C. Jones, Ahmed Kandeil, Jennifer DeBeauchamp, Lance Miller, Thomas Fabrizio, Karlie Woodard, Hannah J. Cochran, Madison C. Owsiany, Bryant M. Foreman, James F. Lowe, Richard J. Webby, and Andrew S. BowmanComments to Author 
Author affiliation: The Ohio State University College of Veterinary Medicine, Columbus, Ohio, USA (N.N. Tarbuck, H.J. Cochran, M.C. Owsiany, B.M. Foreman, A.S. Bowman); St. Jude Children's Research Hospital, Memphis, Tennessee, USA (J. Franks, J.C. Jones, A. Kandeil, J. DeBeauchamp, L. Miller, T. Fabrizio, K. Woodard, R.J. Webby); University of Illinois College of Veterinary Medicine, Urbana, Illinois, USA (J.F. Lowe)

Main Article

Table

Estimated influenza A virus prevalence in retail milk by state and study period in study of retail milk monitoring of influenza A(H5N1) in dairy cattle, United States, 2024–2025*

State No. positive/no. tested (%)
Period 1 Period 2
Arizona 0/5 0/15
Arkansas 3/3 (100) 0/5
California 0/3 33/55 (60)
Colorado 5/20 (25) 0/23
Connecticut 0/2
Florida 0/24
Georgia 0/1 0/3
Idaho 0/7
Illinois 0/21
Indiana 2/21 (9.5) 0/31
Iowa 0/34
Kansas 12/15 (80) 0/5
Kentucky 0/1 0/6
Maryland 0/1 0/1
Massachusetts 0/2
Michigan 5/16 (31.3) 0/28
Minnesota 1/7 (14.3) 0/25
Missouri 1/5 (20) 0/24
Nebraska 0/4 0/9
New Jersey 0/5
New York 0/10 0/23
North Carolina 0/5
Ohio 2/18 (11.1) 0/25
Oklahoma 3/3 (100) 0/12
Pennsylvania 0/15
South Dakota 0/2
Tennessee 0/4
Texas 27/33 (81.8) 0/21
Utah 0/20
Virginia 0/2 0/13
Wisconsin

0/12
Total 61/168 (36.3) 33/477 (6.9)

*The number of states included in surveillance increased from period 1 to period 2. Period 1, March 25–May 3, 2024; period 2, December 9, 2024–January 29, 2025.

Main Article

Page created: January 16, 2026
Page updated: January 30, 2026
Page reviewed: January 30, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external